Corporate Compliance For Life Science Companies

Join us for an insightful program where industry leaders will share their personal stories of navigating compliance challenges at different stages of growth.

As life science companies grow and seek funding, one key factor can make all the difference: corporate compliance. Building a robust compliance framework is essential—not only to meet regulatory requirements but to gain the trust of investors and partners alike.

This program features a panel of seasoned experts from the life sciences sector and trusted service providers who will share real-world experiences of managing compliance and ethics and practical tips to help your company thrive. Learn how establishing strong compliance practices can help companies raise funds and drive sustainable growth. Whether you’re a startup or an established business, this event will provide valuable insights into the importance of compliance in today’s competitive landscape.

Following the moderated presentation, we invite you to participate in an interactive Q&A session to explore this critical topic.

Matt MacNeil, Director,

Matt is a Director at CrossCountry Consulting, a leading provider of specialized finance, operations, and technology advisory services. As a trusted advisor to Fortune 500 companies, emerging growth market leaders, and private equity sponsors, the firm solves today’s most pressing challenges. It creates present and future enterprise value through accounting and risk, technology-enabled transformation, and transaction solutions.

Candice Cantelli Meklis, Senior Vice President of Finance Operations,

Candice is an experienced Finance and Operations leader with a seasoned focus in the Life Science, Pharma, and Digital Health industries. She has extensive experience across various staged companies, including venture capital and consulting firms.

Darlene Deptula-Hicks, Board Member, Acting Chief Financial Officer,

Darlene Deptula-Hicks has worked with emerging growth companies in life sciences for over thirty years. She is recognized for her business breadth, including publicly traded and private companies; her success at capital raising, Initial Public Offerings (IPO), and investor relations; her expertise in growth strategies, including M&A and her global business and operational acumen.

John Hancock, Partner, Co-Char Capital Markets,

John is the Co-Chair of Foley Hoag’s Capital Markets and Public Companies practices; he guides corporate leaders and their boards of directors through complex corporate financing and other transformative transactions, including public offerings, Rule 144A and Regulation S offerings, and mergers and acquisitions.

Claire Jin, Vice President,

Claire is currently on the JPMorgan Commercial Banking Startup Banking team, where she leverages her extensive background in life sciences to support emerging businesses. Her diverse experience has equipped her with a deep understanding of the financial landscape, enabling her to provide invaluable insights and support to startup founders.

This timely event is crucial for anyone involved in the healthcare ecosystem, including board members, CEOs, CFOs, and investors. Don’t miss this opportunity to gain essential insights and practical strategies for navigating compliance at every stage of growth.

Host or Publisher New England Healthcare Executive Network